LeaderPortfolio
Fan
Dong Fan
Rank #2914
CHINAHealthcareMedical devices

Dong Fan

Net Worth
$1.27B
0% (24h)
Dong Fan is a Chinese entrepreneur and the chair of Jafron Biomedical. She is a self-made billionaire with a net worth of $1.3 Billion as of March 25, 2026. Her primary source of wealth comes from the medical devices industry. She is a graduate of Shanghai University of Finance and Economics and Sun Yat-sen University. Dong Fan's career began in 1989 when she founded Jafron Biomedical, which went public on the Shenzhen Stock Exchange in 2016.

How to read Dong Fan's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Dong Fan, we anchor the narrative to Medical devices and Medical devices, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $1.27B alongside global rank #2914, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (CHINA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Details about Dong Fan's early life are limited, but she is a graduate of Shanghai University of Finance and Economics and Sun Yat-sen University, where she obtained a Master of Business Administration.

Rise to Success

Dong Fan's rise to success is tied to her leadership of Jafron Biomedical. The company went public in August 2016, marking a significant achievement in her career. She holds a 48% stake in Jafron.

Key Business Strategies

The key business strategy revolves around Jafron Biomedical and its focus on the medical devices industry. Jafron specializes in the research, development, production, and sales of medical devices. The company's early founding in 1989 shows a long-term commitment to the medical sector.

Philanthropy

Information about Dong Fan's specific philanthropic initiatives is not readily available in the search results.

Career Timeline

2016

Jafron Biomedical IPO

Jafron Biomedical went public on the Shenzhen Stock Exchange.

1989

Founded Jafron Biomedical

Founded Jafron Biomedical, a medical device company.

Key Business Ventures & Holdings

CompanyStakeValue
Jafron Biomedical48.00%

Net Worth History

In-Depth Analysis

Early Life

Details about Dong Fan's early life are limited, but she is a graduate of Shanghai University of Finance and Economics and Sun Yat-sen University, where she obtained a Master of Business Administration.

Rise to Success

Dong Fan's rise to success is tied to her leadership of Jafron Biomedical. The company went public in August 2016, marking a significant achievement in her career. She holds a 48% stake in Jafron.

Key Business Strategies

The key business strategy revolves around Jafron Biomedical and its focus on the medical devices industry. Jafron specializes in the research, development, production, and sales of medical devices. The company's early founding in 1989 shows a long-term commitment to the medical sector.

Philanthropy

Information about Dong Fan's specific philanthropic initiatives is not readily available in the search results.

Data Sources & Methodology

Figures for Dong Fan are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.